Plain-English translation of NCT06718530 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for early warning signs of liver cancer in people with hepatitis C by studying blood samples and genetic markers. Even after successful hepatitis C treatment, some people still develop liver cancer, and this study aims to find better ways to catch it early through simple blood tests and genetic analysis.
Although modern hepatitis C medications work well to eliminate the virus, they don't completely eliminate the risk of liver cancer. This study exists to discover new blood-based markers that could alert doctors years before liver cancer develops, allowing for earlier detection and treatment when it's most effective.
You likely qualify if…
You likely don't qualify if…
You would provide blood samples and complete health questionnaires as part of this research study. The researchers will analyze your blood for specific immune markers and genetic factors that may predict liver cancer risk. This is an observational study, meaning you won't receive any experimental medication—just a screening opportunity that could help advance early detection methods for people with hepatitis C.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy